Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study

INTRODUCTION: Immunotherapy is the fourth leading therapy for lung cancer following surgery, chemotherapy and radiotherapy. Recently, several studies have reported about the potential association between the gut microbiome and therapeutic response to immunotherapy. Nevertheless, the specific composi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Fumihiro, Yamashita, Takanori, Kinoshita, Fumihiko, Takamori, Shinkichi, Fujishita, Takatoshi, Toyozawa, Ryo, Ito, Kensaku, Yamazaki, Koji, Nakashima, Naoki, Okamoto, Tatsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185567/
https://www.ncbi.nlm.nih.gov/pubmed/35676015
http://dx.doi.org/10.1136/bmjopen-2022-061674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185567/
https://www.ncbi.nlm.nih.gov/pubmed/35676015
http://dx.doi.org/10.1136/bmjopen-2022-061674

Ejemplares similares